APOE and Alzheimer disease: In APOE ε4 non-carriers, there were no significant differences in the allele frequency between AD patients and controls, but we observed a lower distribution of GG homozygosity at rs17125924 in the former group, suggesting a protective effect in the recessive model (Table 2).